Australia · Venture startup

Who invested in Agscent

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

HealthcareMedical Devices

Raised 4 months ago

Funding summaryUpdated 26 Oct 2026

$5.0Mraised across 1 round since 2026, from 1 source

Latest round
Venture, $5.0MJul 2026
Investors
1
See who backed them

The rounds

  1. Jul 2026
    Venture$5.0M

    Source recorded

Founders and team

From Agscent's own website: 1 founder, 4 on the team.

Dr. Bronwyn DarlingtonFounder and Managing Director
  • Ailie WebbChief Commercialisation Officer
  • Dr. Andrea RanzoniChief Product & Technology Officer
  • Dr. Flore HervéChief Scientific Officer
  • Warren BinghamChairman

AdvisersDr Jing Li

Everyone who backed them

Flying Fox VenturesVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 2 firms list Agscent as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.

Scale InvestorsAngel networkPer its own site
Mandalay VenturesVC firmPer its own site

Quick answers about Agscent

Who invested in Agscent?

Agscent's investors include Flying Fox Ventures.

How much has Agscent raised?

Agscent has raised $5.0M across 1 round since 2026.

When did Agscent last raise?

Agscent's most recent round was a Venture of $5.0M in Jul 2026.

What was Agscent's biggest round?

Its most recent round, $5.0M in Jul 2026, is also its largest on record.

Who backed Agscent first?

Agscent's first round on record, in Jul 2026, was backed by Flying Fox Ventures.

What stage is Agscent at?

Agscent's latest named round is a Venture, in Jul 2026.

Where is Agscent based?

Agscent is based in Australia.

Companies like Agscent

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.